Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.83 INR | -0.95% |
|
-4.25% | -11.22% |
06/06 | Shelter Pharma Receives Drugs Order Worth $120,000; Shares Jump 14% | MT |
06/06 | Shelter Pharma Limited Informed Secures A Noteworthy Order from Berlin International Medical | CI |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 314.6 | 277.3 | 300.7 | 224.8 | 300.6 | 361.5 |
EBITDA 1 | 1.59 | 1.798 | 2.254 | 1.898 | 30.37 | 81.31 |
EBIT 1 | 0.5989 | 0.6175 | 0.9377 | 0.7366 | 28.68 | 79.67 |
Operating Margin | 0.19% | 0.22% | 0.31% | 0.33% | 9.54% | 22.04% |
Earnings before Tax (EBT) 1 | 0.69 | 0.803 | 0.9386 | 0.6849 | 28.06 | 78.82 |
Net income 1 | 0.5444 | 0.6015 | 0.7083 | 0.5099 | 20.59 | 57.83 |
Net margin | 0.17% | 0.22% | 0.24% | 0.23% | 6.85% | 16% |
EPS 2 | 0.0749 | 0.0825 | 0.0975 | 0.0656 | 2.659 | 7.468 |
Free Cash Flow | - | - | - | - | -0.3969 | -20.79 |
FCF margin | - | - | - | - | -0.13% | -5.75% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 07/09/18 | 26/06/19 | 05/12/20 | 29/11/21 | 03/05/23 | 05/08/23 |
Balance Sheet Analysis
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.3 | 0.98 | - | 0.31 | 13.6 |
Net Cash position 1 | 0.03 | - | - | 3.66 | - | - |
Leverage (Debt/EBITDA) | - | 0.1641 x | 0.433 x | - | 0.0103 x | 0.1667 x |
Free Cash Flow | - | - | - | - | -0.4 | -20.8 |
ROE (net income / shareholders' equity) | 0.71% | 0.79% | 0.96% | 0.72% | 25.9% | 49.3% |
ROA (Net income/ Total Assets) | 0.33% | 0.35% | 0.54% | 0.44% | 15.6% | 29% |
Assets 1 | 163.3 | 170 | 130.6 | 115.1 | 132.3 | 199.1 |
Book Value Per Share 2 | 10.50 | 10.60 | 9.700 | 9.270 | 11.40 | 18.70 |
Cash Flow per Share 2 | 0.1100 | 0.1700 | 0.1800 | 0.4100 | 0.1300 | 0.5500 |
Capex | - | - | - | - | 6.05 | 0.04 |
Capex / Sales | - | - | - | - | 2.01% | 0.01% |
Announcement Date | 07/09/18 | 26/06/19 | 05/12/20 | 29/11/21 | 03/05/23 | 05/08/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-11.22% | 6.77M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 543963 Stock
- Financials Shelter Pharma Limited